SCHEMBL21393323

SCHEMBL21393323

CO/C(=C1/CO1)c1ccnc(COc2cccc(O)c2C=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
BACE1 P56817 4/20 0.32
ERN1 O75460 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4A O75164 2/20 0.31
KDM4B O94953 2/20 0.31
KDM5C P41229 2/20 0.31
KDM5B Q9UGL1 2/20 0.31
APP P05067 1/20 0.30
MAPT P10636 1/20 0.30
NR1H4 Q96RI1 1/20 0.30
JAK2 O60674 1/20 0.30
LCK P06239 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21383373 0.83 ERN1 (0.44) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL27188142 0.72 KDM4E (0.51) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL21383047 0.69 L3MBTL1 (0.42) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL26087615 0.69 RAB9A (0.45) ALDH1A1NPC1RAB9AKDM5BMAPT
SCHEMBL26087769 0.68 KDM5A (0.52) NPC1RAB9AKDM5B
SCHEMBL21385830 0.68 MRGPRX4 (0.56) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL27188169 0.68 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL6027093 0.66 MRGPRX4 (0.55) KDM4EALDH1A1ERN1NPC1RAB9A
SCHEMBL22693427 0.66 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL5756261 0.66 MAPT (0.61) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182938-A1 AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2019-09-26 WO disclosed